In this study, we investigated the impact of BMPR2 mutations on lung development by generating and analyzing airway and alveolar organoids derived from iPSCs obtained from a patient with BMPR2-related pulmonary hypertension (PH) and gene-corrected control iPSCs. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.